Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder Cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. National Implementation of Simulator Training Improves Transurethral Resection of Bladder Tumours in Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Scheduling appointments for postvasectomy semen analysis has no impact on compliance

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Tranexamic Acid in Patients Undergoing Noncardiac Surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Diagnostic Age, Age at Death and Stage Migration in Men Dying with or from Prostate Cancer in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reasons for staying in hospital after video-assisted thoracoscopic surgery lobectomy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. AHA STEROID trial, dexamethasone in acute high-risk abdominal surgery, the protocol for a randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: Morbidity after radical cystectomy (RC) is usually quantified in terms of rates of complications, mortality, reoperations, and readmissions, and length of stay (LOS). The overall burden following RC within the first 90 d following RC may be better described using days alive and out of hospital (DAOH), which is a validated, patient-centred proxy for both morbidity and mortality.

Objective: To report short-term morbidity, LOS, and DAOH within 90 d after RC and risk factors associated with these parameters.

Design setting and participants: The study included 729 patients undergoing RC for bladder cancer at a single academic centre from 2009 to 2019. Data were retrieved from national electronic medical charts.

Outcome measurements and statistical analysis: Multivariate analysis was used to investigate variables associated with a major complication, LOS >7 d, and DAOH <80 d.

Results and limitations: The 90-d complication rate was 80%, including major complications in 37% of cases. Median LOS was 7 d (interquartile range (IQR) 6-9) and median DAOH was 80 d (IQR 71-83) days. Body mass index and the Charlson comorbidity index (CCI) predicted major complications. CCI predicted LOS >7 d and DAOH <80 d.

Conclusions: RC was associated with significant short-term morbidity and DAOH was a good marker for cumulative morbidity after RC. We propose that DAOH should be a standard supplement for reporting surgical outcomes following RC for bladder cancer, which may facilitate better comparison of outcomes across treating institutions.

Patient summary: We studied complications after surgical removal of the bladder for bladder cancer. We assessed a novel patient-centred tool that more accurately describes the total burden of complications after surgery than traditional models. We found that patients with a high body mass index and coexisting chronic diseases had a higher risk of a complicated surgical course.

OriginalsprogEngelsk
TidsskriftEuropean Urology Open Science
Vol/bind28
Sider (fra-til)1-8
Antal sider8
ISSN2666-1691
DOI
StatusUdgivet - jun. 2021

Bibliografisk note

Publisher Copyright:
© 2021 The Author(s)

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

ID: 66480727